Aug. 3, 2026 — Imricor Medical Systems has launched Imricor Cardiovascular, a new vertical that expands the interventional MR (iMR) market for Imricor alongside its electrophysiology and ablation business. Imricor Cardiovascular is designed to support a new model of care that is both clinically meaningful and operationally compelling for hospitals. Cardiac Catheterization Guided by MRFor patients, the value of Imricor Cardiovascular is especially evident in congenital and pediatric heart care, where children with complex heart conditions face repeated procedures over many years. The possibility of cardiac catheterization guided by MR without exposure to ionizing radiation can make a meaningful difference in children’s lives and long-term health. Greg Englehardt, Imricor’s VP of Global Sales, said, “With Imricor Cardiovascular, hospitals can pioneer radiation-free cardiac care, safeguard vulnerable patients, and arm care teams with MR imaging.